Revon Media
  • Newspaper
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Live Edition
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Media
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • About Us
  • Contact Us
No Result
View All Result
  • Newspaper
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Live Edition
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Media
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • About Us
  • Contact Us
No Result
View All Result
Revon Media
No Result
View All Result

GenScript’s state-of-art manufacturing facility in Singapore

GenScript’s state-of-art manufacturing facility in Singapore
Share on FacebookShare on Twitter

GenScript Biotech Corporation (GenScript), the world’s leading life science research tools and services provider, announced on Feb 10, 2022, the opening of a more than 30,000-square-feet facility for highly automated protein and gene preparation services.

The state-of-the-art site marks a significant expansion of the company’s advanced protein and gene platforms and is designed to provide high quality, fast turnaround on products required for new vaccines and therapeutics development and innovations in life sciences.

Supported by the Singapore’s Economic Development Board (EDB), the new production site will support the Asia Pacific region and complements the current production sites in the United States and China.

The opening ceremony was held in a virtual setting inaugurated by Minister of State for Trade and Industry, and Culture, Community and Youth, Alvin Tan and accompanied by Senior Vice President and Head, Healthcare, Singapore Economic Development Board (EDB), Ms Goh Wan Yee.

During the ceremony, GenScript and Diagnostics Development (DxD) Hub, a national platform hosted by the Agency for Science, Technology and Research (A*STAR), signed a memorandum of understanding (MoU) to explore collaborations to build manufacturing capabilities in Singapore.

The new manufacturing facility occupies over 30,000 square feet space at Solaris@Kallang building. The cutting-edge facility in Singapore features a high throughput platform and proprietary technology of GenScript’s protein production to provide higher yield with a shorter turnaround time.

“This is a significant milestone for us as we strengthen our presence in the vibrant and innovative ecosystem in the Asia Pacific, Singapore. The new manufacturing facility will be a regional innovation and excellence hub in the Asia Pacific and increase the productivity of custom protein manufacturing,” said Johnson Wang, President of GenScript Asia Pacific Division.

Dr Ray Chen, President of Life Science Group, GenScript Biotech Corporation, said: “Singapore , the home to GenScript’s Asia Pacific headquarters, it is also a strategic location for us to expand our manufacturing capability to support the fast-growing biotechnology industry.

“With the strong support from EDB, our new facility aims to be the center of a solid regional network to catalyse more collaboration, ultimately spurring more innovation and breakthrough life science.”

Goh said: “GenScript’s decision to set up its new production site and business hub in Singapore is testament to our robust manufacturing infrastructure, R&D and innovation ecosystem, a strong base of biotech talent, and our excellent connectivity to the Asia-Pacific region,” she said.

 

Tags: Foreign NewsGenScriptLife ScienceResearch facilityThe Health 2022The Health Mar/AprtheHealth
Previous Post

Intellect’s US$10m funding deal

Next Post

Shedding light on antibiotics-associated diarrhea

Live Edition Paper

NOV 2020 ePaper

OCT 2020 ePaper


 

Subscribe for free complimentary live editions:

Recent News

  • Mesh Bio raises US$1.8 million seed funding
    September 3, 2021
    Singapore-based healthtech start up Mesh bio has raised US$1.8 million (SG$2.4 […]
  • The halal factor
    March 1, 2021
    Duopharma Biotech Bhd is one of the most prominent players in halal […]
  • Hoping for a better year
    November 29, 2021
    While 2021 has turned out to be worse than expected, there is cautious optimism […]
  • Duopharma’s high productivity amidst innovation focus
    August 16, 2022
    Duopharma Biotech Berhad (Duopharma Biotech) is strengthening its position as a […]
  • Worrisome Year Ahead
    January 1, 2021
    As we begin the new year, several issues and concerns will impact the lives of […]

Connect

Office

Revon Media Sdn Bhd
A member of Revongen Corporation
Headquarters
Revongen Corporation Center,
Level 17, Top Glove Tower, No.16,
Persiaran Setia Dagang,Setia Alam,
Seksyen U13, 40170 Shah Alam,
Selangor Darul Ehsan, Malaysia.

Contact

Tel: +603 3359 1166
Fax: +6 03 3358 0303

Copyright © 2021 Revon Media Sdn Bhd. A publication of Revon Media Sdn Bhd. About Us | Contact Us | Privacy Policy | Terms of use

No Result
View All Result
  • Newspaper
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Live Edition
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Media
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • About Us
  • Contact Us

© 2021 Revon Media Sdn Bhd. A publication of Revon Media Sdn Bhd

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist